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Abstract
Background: While the transcription of innate immunity genes in response to bacterial infection has been well-
characterised in the Drosophila model, we recently demonstrated the capacity for such transcription to evolve in
flies selected for improved antibacterial defense. Here we use this experimental system to examine how insects
invest in constitutive versus infection-induced transcription of immunity genes. These two strategies carry with
them different consequences with respect to energetic and pleiotropic costs and may be more or less effective in
improving defense depending on whether the genes contribute to humoral or cellular aspects of immunity.
Findings: Contrary to expectation we show that selection preferentially increased the infection-induced expression
of both cellular and humoral immunity genes. Given their functional roles, infection induced increases in
expression were expected for the humoral genes, while increases in constitutive expression were expected for the
cellular genes. We also report a restricted ability to improve transcription of immunity genes that is on the order of
2-3 fold regardless of total transcription level of the gene.
Conclusions: The evolved increases in infection-induced expression of the cellular genes may result from specific
cross talk with humoral pathways or from generalised strategies for enhancing immunity gene transcription. A
failure to see improvements in constitutive expression of the cellular genes suggests either that increases might
come at too great a cost or that patterns of expression in adults are decoupled from the larval phase where
increases would be most effective. The similarity in fold change increase across all immunity genes may suggest a
shared mechanism for the evolution of increased transcription in small, discrete units such as duplication of cis-
regulatory elements.
Introduction
Recently, using selection experiments, we examined the
ability of Drosophila melanogaster to evolve in response
to systemic infection by the opportunistic bacterial
pathogen, Pseudomonas aeruginosa [1]. The evolved flies
demonstrated an improved defense as measured by an
increase in fly survival in response to infection from 15
to 70%. The genetic basis of the evolved response was
examined using microarrays and was characterised by
increased expression for many immunity related genes.
The evolved defense was costly, as evidenced by
decreases in egg viability and longevity and the rapid
loss of the increased survival when selection was
removed. While the original study demonstrated the
involvement of both cellular and humoral aspects of
insect immunity in the evolved defense, the design did
not allow for the partitioning of the total transcriptional
change into its constitutive versus infection-induced
components. These two avenues for transcriptional
change should have different energetic or pleiotropic
costs and [2] may be more or less effective in improving
immunity depending on the functional role of the gene.
The original study also only focused on genetic changes
in males and so did not determine if females were
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mechanism.
The humoral immune response in insects is character-
ized by cascades of genes whose expression is controlled
by a range of recognition proteins that bind pathogen
cell wall components and end with the production of a
range of secreted host protei n st h a tt a r g e tb a c t e r i af o r
destruction [3]. Exposure to infection can increase the
transcription of these genes substantially, ie from 10-100
fold for some of the genes encoding antimicrobial pep-
tides [4]. We hypothesized that selection for improved
defense would lead to further increases in the transcrip-
tion of these genes upon exposure to infection. This
would represent a targeted strategy, producing these
molecules only when needed at a point in the infection
process where they normally act against invading bac-
teria. The transient and inducible nature of this aspect
of immunity might suggest, however, that flies are
already be operating this response at or near maximal
transcriptional capacity, potentially limiting the size of
gains we might see. Increasing the constitutive expres-
sion of these humoral genes, though more costly, could
also be beneficial. A greater number of circulating anti-
microbial peptides prior to exposure could confer an
enhanced ability to contain or curtail infection and
recent work has suggested that fly genotypes with
greater constitutive expression of these genes are better
able to control infection [5].
The genes that define the cellular response of immu-
nity underpin processes like encapsulation, lytic ability
and phagocytosis. The cellular response has been shown
to be highly effective in early infection, including the
recent suggestion that the inducible humoral response
may exist only for “clean up” while the cellular response
serves as the frontline of antibacterial defense [6]. The
expression of these genes early in development can
determine subsequent immunological traits in adults
like the number and quality of circulating hemocytes
[3,7]. Many of these genes may also have pleiotropic
roles to play with respect to early development [8,9]. In
our study, flies with an evolved defense also developed
more rapidly, which may have resulted from such pleio-
tropy. Several key studies in recent years have high-
lighted the cost of investing specifically in cellular
immunity with respect to various trade-offs in life his-
tory traits [6,10-12]. In contrast to the secreted products
of the humoral response, we would expect that only
increases in the constitutive expression of these genes
would result in improved antibacterial defense. Any
infection induced increases in expression should theore-
tically be “too late” or too slow convert to infection
fighting ability [13]. Given the significant improvement
in survival of selected flies, the cost of this improve-
ment, the concomitant increase in developmental rate
and the likely point of action of these proteins early in
development [1], we expected to see evolution of
increased constitutive expression for the cellular immu-
nity genes.
Here we compare the expression patterns of immunity
genes between evolved and unevolved flies in both the
constitutive and infection-induced states. In so doing,
we are able to partition the relative investment into con-
stitutive versus infection-induced transcription of genes
representing both humoral and cellular aspects of
immunity due to selection and understand how invest-
ment in these different strategies may form the basis of
fly immunity.
Materials and Methods
Fly and bacterial culture and the selection regime are as
previously reported [1] but are described briefly below.
Female flies generated from the previous selection
experiment are then screened here for immunity gene
transcriptional profiles as an addition to the original
study.
Fly and Bacterial Culture
Brisbane (BNE) base stock was founded from 26 females
D. melanogaster caught around the University of
Queensland St Lucia campus in August 2006. The flies
were initially treated with 0.5% penicillin and streptomy-
cin in the diet for one generation [14] and then pas-
saged without antibiotic on standard cornmeal diet
supplemented with excess yeast for more than 10 gen-
erations before the start of the selection experiment. P.
aeruginosa PA01 was cultured in LB medium supple-
mented with 100 mg ml
-1 ampicillin at 37°C on a rotory
shaker [15]. For infection, the concentration of an over-
night bacterial culture was adjusted to an optical density
(OD) of 0.5 ± 0.05 measured spectrometrically at 600
nm. The culture was then diluted 100 fold using sterile
LB. This OD was determined at the start of the selec-
tion experiments to achieve a fly population kill rate of
80-90%. To determine the number of bacterial cells
used to infect each fly, individual flies were ground with
ap e s t l ei na nE p p e n d o r ft u b ew i t h2 0 0μlo f1 0m M
MgSO4 and spread on LB plates supplemented with 100
mg ml
-1 ampicillin immediately after infection [16]. The
average infective dose per fly was 3109 ± 635 bacterial
cells.
Selection Regime and Measurement of Defense
The base stock population of flies was split into 3
selected and 3 unselected lines. Selected lines were
infected each generation with P. aeruginosa PA01 and
the survivors allowed to populate the subsequent gen-
eration. Selection was applied for 10 generations. For
each round of selection, 8 sub-replicate populations
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ginosa. Mated flies aged to 4-7 days old were anaesthe-
tized with CO2 and infected as previously described by
dipping a sterile needle in the bacterial culture and pier-
cing the intrathoracic region of the fly [17]. Fly mortality
was then monitored for each population over 48 hours.
Survivors from each of the 8 sub-replicates were pooled
into a single population to seed the subsequent genera-
tion. The unselected lines were not infected during the
breeding regime, but were exposed to the same bottle-
neck in population size as their paired selected lines by
randomly selecting a set of individuals to found the next
generation. Survival in response to infection was moni-
tored each generation in selected lines and at two time
points, G6 and G10 in the unselected lines. While survi-
val rates in the selected lines rose rapidly from 15% at
G0 to 70% by G10, survival rates of unselected lines
remained low. Selection was then removed at G10 for 5
generations and survival of the selected lines reverted to
pre selection levels [1].
Immunity Gene Expression at G10 after selection
There were three replicate lines in the original selection
experiment (S1-S3) that all exhibited similar levels of
antibacterial defense after selection. For this study we
have focused on just one of the lines (S1) and its paired
unselected line (C1). At G10,4t o7d a yo l dw h o l e
female flies from these two lines were either collected
directly for constitutive measures of expression or first
infected with P. aegurinosa to measure infection-
induced expression. For the infected treatment, flies
were collected 8 hours post infection with P. aeruginosa.
Five pools of 20 flies each were collected to represent
each treatment for all combinations of selected/unse-
lected × infected/uninfected. All flies were snap frozen
in liquid nitrogen and extracted for Total RNA using
Trizol (Invitrogen Corp., Carlsbad, CA) as per the man-
ufacturer’s instructions. Total RNA was treated with 2
μl of DNase I (Roche) for 30 minutes at 37°C in a 20 μl
reaction to eliminate genomic DNA.
Real-time PCR (RT-PCR) was used to measure the
expression of a set of 8 genes identified from our pre-
vious microarray study as they were shown to be
involved in improved defense to P. aeruginosa infection
in male flies [1]. Four of the genes represent the
humoral (DiptB, dros4, PGRP-SB1, PGRP-SD) and 4
represent the cellular (Bc, eater, Sr-CI, TepII) immune
r e s p o n s e .P r i m e rs e q u e n c e so f6o ft h eg e n e sw e r ea s
reported in the initial study. In addition we designed
primers for PGRP-SB1 (FBtr0075348); Forward 5’-3’
TTAGCTCTATCCGCCAATGC, Reverse 5’-3’
CCCTTGTGATCCGACTGAAT that generated a 191
bp product and DiptB (FBtr0086621); Forward 5’-3’
CTGGCATATGCTCCCAATTT, Reverse 5’-3’
ATAGGGTCCACCAAGGTGCT that generated a 198
bp product. The gene fus, (FBgn0023441), which is
involved in an epidermal growth factor receptor signal-
ing pathway [18], was employed a reference gene (For-
ward 5’-3’ AAAGTGGTGGAAGCAACAGG, Reverse 5’-
3’ CGCACACAAACTCGAAAAGA, 158 bp product) as
it is was shown not to change in response to infection
or selection in the original microarray analysis [1].
There is also no evidence that female expression should
differ from that of males per the meta analysis of 13 stu-
dies (Male/Female ratio = 1.07, P = 0.21) in the Sebida
database [19].
Approximately 0.5 μg of total RNA was first reverse
transcribed using random primers and SuperScript III
reverse transcriptase (Invitrogen) according to manufac-
turer’s protocols. Then RT-PCR was performed on
Rotor-gene 6000 (Corbett Life Science, Sydney, NSW)
using Platinum
®SYBR
®Green (Invitrogen Inc, Carlsbad,
CA) according to manufacturer’s instructions. For each
sample, a mastermix of 2 μlR N a s e - f r e ew a t e r ,5μlo f
SYBR Supermix and 0.5 μl of each primer (10 μM) was
added to 2 μl of cDNA. Three technical replicates were
run for each biological replicate. The cycling protocol
was as follows; 1 cycle UDG incubation at 50°C for 2
minutes, 1 cycle Taq activation at 95°C for 2 minutes,
40 cycles of denaturation at 95°C for 5 s, annealing at
60°C for 5 s, extension at 72°C for 15 s, fluorescence
acquisition at 78°C, and 1 cycle of melt curve analysis
from 68-95°C in 1°C steps. Mean Cycle Threshold (CT)
and mean amplification efficiency (E) per biological
replicate was calculated across technical replicates using
Rotor-Gene 6000 Series Software ver.1.7.75 (Info-ZIP
Pty Ltd.) for analysis.
Expression ratios were calculated by the Q-gene appli-
cation [20]. The software transforms the logarithmic
scaled raw data unit into the linear unit of normalized
expression (NE) and expresses it as a ratio to the refer-
ence gene. The data were then analysed using general
linear models per gene with the factors, infection status
(infected vs uninfected) and treatment (selected vs unse-
lected) using Statistica 8.0 (StatSoft, Inc.). To control
the occurrence of false positive for independent test sta-
tistics, test P-values were corrected using the Benjamini
and Hochberg method [21]. Ratios were then created of
selected/unselected for display only by random pairing
of replicates (Figure 1).
Results
Response to Selection
The transcription of all genes responded to infection
and all but TepII and PGRP-SD exhibited altered tran-
scription in response to selection (Tables 1 and 2). By
comparing directly the fold change in expression due to
selection in the constitutive state (Figure 1A: selected/
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induced state (Figure 1B: selected/unselected, infection),
we can see the relative investment in these two different
aspects of the immune response. By examining the pat-
tern of significance both in the main treatment effect of
selection and in its interaction with infection (Tables 1
and 2), we see that most of the transcriptional change in
response to selection occurs only in the presence of
infection (Figure 1). Only dros4 exhibited similar levels
of fold increase after selection both in the constitutive
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Figure 1 Fold change in expression in response to selection (as opposed to total transcriptional output) in the constitutive (A) and
infection induced (B) states. Mean ratios of selected/unselected flies ± sem for random pairings of biological replicates.
Table 1 Gene specific general linear models for the effects of selection and infection on expression of humoral genes
df DiptB dros4 PGRP-SB1 PGRP-SD
FPF P FPFP
Intercept 1 51.97 0.00 64.73 0.00 58.89 0.00 51.28 0.00
Selection 1 11.91 0.0032 8.60 0.0097 9.34 0.0075 3.80 0.068
Infection 1 50.98 < 0.0001 19.32 < 0.001 51.17 < 0.0001 38.58 < 0.0001
Selection*Infection 1 11.85 0.0033 2.68 0.12 8.93 0.0086 3.19 0.093
Error 16
Degrees of freedom (df), F-statistics (F) and the p-value (P), bold denotes significance at P < 0.05 after Benjamini-Hochberg [21] multiple test correction.
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DiptB, PGRP-SB, Bc, eater and Sr-CI demonstrate sig-
nificant interactions, Selection*Infection, with transcrip-
tional changes that are only present after infection.
PGRP-SD though, not statistically significant (P =
0.068), exhibits a similar trend. The changes in these
genes were all in the direction of increased transcrip-
tion, save Bc, that showed a greater decrease upon expo-
sure to infection. The mean increase in infection
induced transcription due to selection was modest, typi-
cally 2-3 fold (Figure 1). The impact of a 2-fold increase,
however, can be quite substantial with respect to total
transcription levels for very highly expressed genes such
as PGRP-SB1, PGRP-SD1 and DiptB [4].
Comparison to Previous Study
The genes studied here were identified from a previous
microarray study in males where their transcription was
shown to slightly increase (~2 fold on average) in
response to selection in the presence of infection [1].
The expression of several of these genes (PGRP-SD, Sr-
CI, TepII, eater, Bc) was also confirmed in males using
qRT-PCR. In general selected females demonstrate
increases in transcription of the same immunity genes
(Figure 1) with the exception of TepII and Bc. The mag-
nitude of the female transcriptional response to selec-
tion also appears greater, but direct comparisons of
expression values between males and females are likely
to be confounded by their variation in size and cell
count (in particular with respect to the embryo) and any
potential sex bias in the reference gene.
Discussion
In contrast to expectation, we demonstrated that selec-
tion either produced similar investments into constitu-
tive and infection-induced transcription (dros4) or
invested preferentially in the inducible response
(PGRP-SB1, DiptB, Sr-CI, eater, Bc). For PGRP-SB1,
DiptB and dros4 heightened inducible expression
should confer improved humoral immunity [3]. A fail-
ure to see selection induced increases in constitutive
expression of these genes may be explained either by
pleiotropic or energetic costs or a decoupling of
expression between larval and adult stages. Recent
work examining the constitutive expression of the
immunity genes, Dipt and dro, has shown that they
vary with respect to how they are controlled, demon-
strating decoupled and coupled patterns of expression,
respectively between larvae and adults [22]. If the
genes studied here have decoupled control, any
changes in the constitutive expression in larvae, may
not be present in the adult where we surveyed expres-
sion. In contrast, dros4 may be a candidate for coupled
control where constitutive changes in larvae are main-
tained into adulthood.
For the cellular genes, the benefits of increased tran-
scription upon exposure to infection are not clear. Pre-
vious genome wide screens of transcription have not
revealed induced expression of Sr-CI or eater upon
immune challenge with bacteria [4,5,23,24]. Both genes
encode transmembrane proteins in insect plasmatocytes
that act as scavenger receptors and are required for
recognition of pathogens and effective phagocytosis
[25,26]. As they are not secreted, it is difficult to under-
stand how their enhanced transcription upon infection
would produce immediate benefits with respect to
microbial defense. The increased transcription seen here
in response to selection may instead serve to directly
trigger transcription of other more effective genes.
Although the molecular cross talk between the various
immunity pathways is not well characterised [27], it has
been demonstrated for example that expression of eater
is required for complete activation of Defensin [28].
Alternatively, the heightened expression of these genes
may not be adaptive. The selected lines may have
arrived at genetic solutions where transcription of
immunity genes is heightened across the board in a
non-specific manner via transcription factors. As above
the failure to see increases in constitutive expression in
the cellular genes suggests they may be strong candi-
dates for a decoupled model of larval to adult genetic
control. In any case, these findings suggest that there is
not a global increase in the constitutive expression of
cellular immunity genes into adulthood that may explain
the rapid development via pleiotropy or the costly trade-
offs seen in host fitness like longevity and egg viability.
Table 2 Gene specific general linear models for the effects of selection and infection on expression of cellular genes
df Bc eater Sr-CI TepII
FP F P F P F P
Intercept 1 54.75 0.00 109.61 0.00 210.63 0.00 73.96 0.00
Selection 1 10.14 0.0057 7.67 0.013 24.02 0.00016 0.11 0.73
Infection 1 15.36 0.0012 11.23 0.0040 58.26 < 0.0001 37.24 < 0.0001
Selection*Infection 1 6.37 0.022 7.16 0.016 13.99 0.0017 0.17 0.68
Error 16
Degrees of freedom (df), F-statistics (F) and the p-value (P), bold denotes significance at P < 0.05 after Benjamini-Hochberg [21] multiple test correction.
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scription investments.
The transcription of only one gene, TepII, clearly did
not respond to selection. TepII’s capacity to respond to
bacterial challenge [4,5,13,24] and in particular infection
with a particular P. aeruginosa strain [23] has been
documented previously. There is also evidence that the
transcriptional regulation of TepII is at least in partly
under the control of the Toll & Imd pathways [4]. More
akin to the humoral genes, the encoded protein, is
secreted and acts as an opsonin during the process of
targeting foreign bacterial invaders for destruction [29].
Production of TepII is required for phagocytosis of bac-
teria [30] and is involved with wound healing [31]. A
failure to improve transcription levels of TepII upon
selection may indicate a lack of genetic diversity in the
population, although this is unlikely given the response
of all other genes. There may also be negative pleiotro-
pic effects associated with heightened transcription. Evi-
dence of TepII’s involvement in cellular functions other
than immunity is lacking, although it expressed in
oocytes [32]. Interestingly, a number of studies have
demonstrated strong signatures of positive selection in
the protein coding regions of TepII [33-35] where it is
thought that variable sequence diversity and the produc-
tion of multiple isoforms [36] may underpin the ability
to bind diverse pathogens. The evolution of such diver-
sity within the gene rather may provide a more effective
avenue to improved defense for the insect rather than
increased transcription. This is in contrast with a recent
study on eater, suggesting that selection for intronic var-
iation rather than protein-coding diversity may have
formed the basis of a selective sweep in Drosophila [37].
The fold increases in transcription brought about by
selection ranged only from 2 to 3 for all of the various
genes. Given that the genes vary widely in their total
level of transcription, it is unlikely that the limiters to
the degree of transcriptional improvement can be
ascribed to cost. Instead it suggests that a shared evolu-
tionary mechanism for discrete increases in transcrip-
tional output may be operating for multiple genes or at
least independently at least once for each immune path-
way represented here. One possible model includes an
evolved increase in the multiplicity of cis-regulatory
regions [38,39] as that has been documented previously
for yeast [40], Drosophila [41] and C. elegans [42].
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